Rasagiline
NDC 33342-308, Rasagiline, tablet, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-308
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208866
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RASAGILINE MESYLATE.5 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-308-07 | 33342030807 | 30 TABLET in 1 BOTTLE (33342-308-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e8771c7e-5ecf-47dc-a0fd-4d12e85631a6NADAC price for package 33342030807
GET /v1/drugs/nadac/33342030807
Use it
Look up 33342-308 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-308 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-308. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.